The Bruntwood SciTech network is home to some of the UK’s most pioneering science companies, from small medtech startups and scaleups, all the way through to global life science companies that are uncovering world-leading discoveries, creating new medicines and shaping the future of our healthcare.
So who are some of the UK’s most innovative life science businesses at the forefront of helping to create a fairer and healthier world?
Five months, five companies: Life-changing ideas, game-changing support. Accelerate@Babraham, the bio-entrepreneurial incubator initiative founded and developed by the Babraham Research Campus - supported by key industry and investor organisations - opens applications for its 2021/22 cohort today.
Leading pharmaceutical contract development and manufacturing organisation (CDMO) Quay Pharmaceutical has been honoured with a Queen’s Award for Enterprise, the UK’s highest accolade for business success. The company won its award for International Trade.
Scientists across Norwich Research Park institutes are part of a major integrated UK research-industry programme led by The Alan Turing Institute, seeking out the best talent in AI and data science, developing bioscience leaders and supporting the UK economy.
Coulter Partners was very pleased to partner recently with OxSonics® Therapeutics, a world leader in the development of ultrasound-based drug delivery systems for the treatment of cancer, to secure the appointment of Dr Allison Jeynes as non-executive Chair of the Board of Directors.
The RSA Group, a leading Life Sciences Executive Search firm, is delighted to announce the placement of Sharon Curran as a new independent Non-Executive Director at Clinigen Group, a global, specialist pharmaceutical services and products platform focused on providing ethical access to medicines.
Leading pharmaceutical and biotech product development consultancy, Boyds has announced the appointment of Neil Chakrabarti as Chief Financial Officer.
The appointment comes as the company reported a record-breaking 25 percent growth in turnover as demand for its specialist services continues to grow.
Medannex Ltd (Edinburgh) this week received multiple awards in recognition of notable successes in
several key areas. The late-stage biopharmaceutical company, developing novel treatments for cancers
and autoimmune diseases, was declared the winner in all three categories in which it was nominated at
Scotland’s Life Sciences Annual Awards.